A Novel FAM83H Truncation Mutation Disrupts Enamel Mineralization in Autosomal Dominant Hypocalcified Amelogenesis Imperfecta
Clinical and Experimental Dental Research · 2026
DOI: 10.1002/cre2.70431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dental Research, 2026. Verfasst von Yue Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guanghua School and Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Institute of Stomatological Research, Sun Yat-sen Un…. Hauptthemen laut MEDLINE: Amelogenesis Imperfecta, Dental Enamel, Proteins. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Objectives
Autosomal dominant hypocalcified amelogenesis imperfecta (ADHCAI; OMIM#130900) is a hereditary enamel defect caused by truncation mutations in FAM83H , though the underlying pathogenic mechanisms remain incompletely understood. This study aimed to identify novel FAM83H mutations in a Chinese family with ADHCAI and to investigate their functional consequences on enamel formation. Materials and Methods A three‐generation ADHCAI family underwent clinical and genetic evaluation. Whole‐exome sequencing and Sanger sequencing were used for mutation identification. The proband's enamel was analyzed by scanning electron microscopy with energy‐dispersive X‐ray spectroscopy (SEM‐EDX). Structural impacts of the mutation were predicted bioinformatically (PSIPRED, SWISS‐MODEL). Patient‐derived periodontal ligament cells (PDLCs) were assessed by Western blot, immunofluorescence, and quantitative real‐time PCR for key enamel matrix proteins (AMELX, AMBN, ENAM) and osteogenic markers (RUNX2, ALP).
Results
A novel heterozygous nonsense mutation (c.1819G>T, p.(Glu607*)) in FAM83H was identified, resulting in a C‐terminally truncated protein lacking 573 residues that mislocalizes from the cytoplasm to the nucleus. SEM‐EDX revealed disorganized enamel ultrastructure, a reduced calcium‐to‐phosphorus ratio, and increased porosity. Functional analysis in PDLCs showed coordinated downregulation of enamel matrix proteins and osteogenic markers, indicating a dual regulatory role for FAM83H in biomineralization.
Conclusions
Our findings are consistent with the “presecretory pathogenesis” model for ADHCAI, wherein nuclear‐mislocalized truncated FAM83H may disrupt enamel mineralization partly through transcriptional suppression of matrix components. This expands the FAM83H mutational spectrum, offers preliminary mechanistic insight, and suggests potential targets for pre‐eruptive therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guanghua School and Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Institute of Stomatological Research, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Ganzhou Weile Dental Hospital, Ganzhou, Jiangxi, China.
ORCID-Profile: Yue Wang, Hongfei Chen, Jiyong Lai, Xueqing Huang, Yanyu Huang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wang, Y., Chen, H., Lai, J., Huang, X., & Huang, Y. (2026). A Novel FAM83H Truncation Mutation Disrupts Enamel Mineralization in Autosomal Dominant Hypocalcified Amelogenesis Imperfecta. Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.70431
Vancouver
Wang Y, Chen H, Lai J, Huang X, Huang Y. A Novel FAM83H Truncation Mutation Disrupts Enamel Mineralization in Autosomal Dominant Hypocalcified Amelogenesis Imperfecta. Clinical and Experimental Dental Research. 2026. doi:10.1002/cre2.70431
BibTeX
@article{Wang2026,
author = {Wang, Yue and Chen, Hongfei and Lai, Jiyong and Huang, Xueqing and Huang, Yanyu},
title = {A Novel FAM83H Truncation Mutation Disrupts Enamel Mineralization in Autosomal Dominant Hypocalcified Amelogenesis Imperfecta},
journal = {Clinical and Experimental Dental Research},
year = {2026},
doi = {10.1002/cre2.70431}
}
EUVIMED